Which hedge funds own ARDT? ARDENT HEALTH INC, Q2 2026 13F holders
21 tracked hedge funds disclosed a position in ARDT (ARDENT HEALTH INC) in their Q2 2026 13F filings, worth $51.5m in total. The largest holder by portfolio weight is Goldentree Asset Management LP at 0.9% of its book. 5 opened a new position this quarter: Fox Run Management, L.L.C., Walleye Capital LLC, Aristeia Capital, L.L.C., Point72 Asset Management, L.P.. 5 exited: Moore Capital Management, LP, Numerai GP LLC, Y-Intercept (Hong Kong) Ltd.
- 21
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 5
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 5
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $2.4m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $2.3m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $51.5m
- Combined value Sum of the holders' reported positions in the security.
- 1.7%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Moore Capital Management, LP | 0.05% | $1.4m |
| Numerai GP LLC | 0.02% | $230k |
| Y-Intercept (Hong Kong) Ltd | 0.01% | $401k |
| Brevan Howard Capital Management LP | 0.0% | $93.3k |
| Schonfeld Strategic Advisors LLC | 0.0% | $107k |
Ownership over time
Who discovered ARDT first? Beta
| Goldentree Asset Management LP | Q3 2024 | −0.8 pts |
| CastleKnight Management LP | Q3 2024 | −0.9 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.